tarenflurbil has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, GZ; Jacobsen, JS; Rutkowski, JL; Wan, HI | 1 |
| Alva, G; Hara, J; Hendrix, S; Lee, MD; Mangrola, T; Shankle, WR | 1 |
2 other study(ies) available for tarenflurbil and Disease Exacerbation
| Article | Year |
|---|---|
Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.
Topics: Alzheimer Disease; Animals; Biomarkers; Clinical Trials as Topic; Disease Progression; Drug Discovery; Flurbiprofen; Humans; Patient Selection; Reproducibility of Results; Translational Research, Biomedical; Treatment Failure | 2009 |
Hierarchical Bayesian cognitive processing models to analyze clinical trial data.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Amyloid Precursor Protein Secretases; Bayes Theorem; Clinical Trials, Phase III as Topic; Cognitive Dysfunction; Disease Progression; Double-Blind Method; Female; Flurbiprofen; Humans; Male; Mental Recall; Models, Psychological; Multicenter Studies as Topic; Nerve Tissue Proteins; Neuropsychological Tests; Nootropic Agents; Normal Distribution; Randomized Controlled Trials as Topic; Research Design; Severity of Illness Index | 2013 |